Confronting the “lethal duo” in the ICU: early identification of Aspergillus–Mucorales co-infection using a clinical-immuno-inflammatory signature
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1779186 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Hongqiang Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Nanjing Drum Tower Hospital, Clinical College of Xuzhou Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Coinfection, Mucormycosis, Aspergillosis, Mucorales. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Commission of Health.
Abstract (Originalsprache)
Background
Co-infection with Aspergillus and Mucorales in the intensive care unit (ICU) represents a devastating syndrome with high mortality that is frequently clinically occult. Clinically distinguishing this co-infection from invasive pulmonary aspergillosis (IPA) is challenging but critical for tailoring precise antifungal strategies.
Methods
We conducted a single-center, retrospective observational study involving 93 critically ill patients (75 with Aspergillus infection and 18 with co-infection) admitted between 2017 and 2025. We compared clinical characteristics, inflammatory markers, and immunophenotypes between groups. A three-stage variable selection strategy integrating univariable regression pre-screening, multi-algorithm importance ranking (LASSO, Ridge, and Random Forest), and clinical applicability filtering was employed to identify predictors for a multivariable logistic regression nomogram.
Results
The co-infection group exhibited substantially higher ICU mortality than the sole Aspergillus group, although the difference did not reach statistical significance (72.2% vs. 53.3%, p = 0.24).Kaplan–Meier analysis demonstrated that initiation of amphotericin B within <7 days of diagnosis or strong clinical suspicion was significantly associated with improved survival (log-rank p < 0.0001). A three-stage variable selection strategy integrating univariable regression, multi-algorithm importance ranking (LASSO, Ridge, and Random Forest), and clinical applicability filtering identified four key predictors. The resulting multivariable logistic regression nomogram — incorporating NK cell count, C-reactive protein, corticosteroid use history, and Gram-positive bacterial co-infection — demonstrated robust discrimination (AUC = 0.878, 95% CI: 0.789–0.967), with good calibration (Hosmer–Lemeshow p = 0.849) and stability on internal validation (cross-validated AUC = 0.860).
Conclusion
Aspergillus and Mucorales co-infection constitutes a distinct, high-mortality clinical entity in the ICU. The developed nomogram, integrating clinical, immunological, and inflammatory features, may facilitate the early identification of high-risk patients and guide timely initiation of Mucorales -active therapy to improve prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, Nanjing Drum Tower Hospital, Clinical College of Xuzhou Medical University, Nanjing, China.
- Department of Intensive Care Unit, Nanjing Drum Tower Hospital, Nanjing, China.
- Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, China.
- Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China.
Förderung
- Jiangsu Commission of Health
Zitieren
APA
Xie, H., Gu, J., Cui, J., Feng, M., Cui, Y., Wang, B., Li, Y., Zhang, B., & Chen, M. (2026). Confronting the “lethal duo” in the ICU: early identification of Aspergillus–Mucorales co-infection using a clinical-immuno-inflammatory signature. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1779186
Vancouver
Xie H, Gu J, Cui J, Feng M, Cui Y, Wang B, et al. Confronting the “lethal duo” in the ICU: early identification of Aspergillus–Mucorales co-infection using a clinical-immuno-inflammatory signature. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1779186
BibTeX
@article{Xie2026,
author = {Xie, Hongqiang and Gu, Jiaxu and Cui, Junjie and Feng, Mengwen and Cui, Yonghui and Wang, Baoxia and Li, Yi and Zhang, Beiyuan and Chen, Ming},
title = {Confronting the “lethal duo” in the ICU: early identification of Aspergillus–Mucorales co-infection using a clinical-immuno-inflammatory signature},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1779186}
}
EUVIMED